EP1682672A1 — Method of detecting predisposition to high altitude pulmonary edema
Assigned to Council of Scientific and Industrial Research CSIR · Expires 2006-07-26 · 20y expired
What this patent protects
The present invention relates to a method for the detection of predisposition to high altitude pulmonary edema (HAPE). It particularly relates to an allelic variants of iNOS (inducible nitric oxide synthase) gene, which has been found to be related with the prevalence of HAPE.
USPTO Abstract
The present invention relates to a method for the detection of predisposition to high altitude pulmonary edema (HAPE). It particularly relates to an allelic variants of iNOS (inducible nitric oxide synthase) gene, which has been found to be related with the prevalence of HAPE.
Drugs covered by this patent
- Inomax (NITRIC OXIDE) · Vero Biotech Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.